DE511468C - Verfahren zur Darstellung von 5-Chlor-2-amino-1-methoxybenzol - Google Patents

Verfahren zur Darstellung von 5-Chlor-2-amino-1-methoxybenzol

Info

Publication number
DE511468C
DE511468C DEI33269D DEI0033269D DE511468C DE 511468 C DE511468 C DE 511468C DE I33269 D DEI33269 D DE I33269D DE I0033269 D DEI0033269 D DE I0033269D DE 511468 C DE511468 C DE 511468C
Authority
DE
Germany
Prior art keywords
methoxybenzene
chloro
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DEI33269D
Other languages
English (en)
Inventor
Dr Wilhelm Fitzky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
IG Farbenindustrie AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IG Farbenindustrie AG filed Critical IG Farbenindustrie AG
Priority to DEI33269D priority Critical patent/DE511468C/de
Application granted granted Critical
Publication of DE511468C publication Critical patent/DE511468C/de
Expired legal-status Critical Current

Links

DEI33269D 1928-01-18 1928-01-18 Verfahren zur Darstellung von 5-Chlor-2-amino-1-methoxybenzol Expired DE511468C (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DEI33269D DE511468C (de) 1928-01-18 1928-01-18 Verfahren zur Darstellung von 5-Chlor-2-amino-1-methoxybenzol

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEI33269D DE511468C (de) 1928-01-18 1928-01-18 Verfahren zur Darstellung von 5-Chlor-2-amino-1-methoxybenzol

Publications (1)

Publication Number Publication Date
DE511468C true DE511468C (de) 1930-10-30

Family

ID=7188370

Family Applications (1)

Application Number Title Priority Date Filing Date
DEI33269D Expired DE511468C (de) 1928-01-18 1928-01-18 Verfahren zur Darstellung von 5-Chlor-2-amino-1-methoxybenzol

Country Status (1)

Country Link
DE (1) DE511468C (de)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6344476B1 (en) 1997-05-23 2002-02-05 Bayer Corporation Inhibition of p38 kinase activity by aryl ureas
US7678811B2 (en) 2002-02-11 2010-03-16 Bayer Healthcare Llc Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors
US7838541B2 (en) 2002-02-11 2010-11-23 Bayer Healthcare, Llc Aryl ureas with angiogenesis inhibiting activity
US7897623B2 (en) 1999-01-13 2011-03-01 Bayer Healthcare Llc ω-carboxyl aryl substituted diphenyl ureas as p38 kinase inhibitors
US8076488B2 (en) 2003-02-28 2011-12-13 Bayer Healthcare Llc Bicyclic urea derivatives useful in the treatment of cancer and other disorders
US8110587B2 (en) 2002-02-11 2012-02-07 Bayer Healthcare Llc Aryl ureas as kinase inhibitors
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US8207166B2 (en) 2004-04-30 2012-06-26 Bayer Healthcare Llc Substituted pyrazolyl urea derivatives useful in the treatment of cancer
US8637553B2 (en) 2003-07-23 2014-01-28 Bayer Healthcare Llc Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
US8796250B2 (en) 2003-05-20 2014-08-05 Bayer Healthcare Llc Diaryl ureas for diseases mediated by PDGFR

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6344476B1 (en) 1997-05-23 2002-02-05 Bayer Corporation Inhibition of p38 kinase activity by aryl ureas
US7897623B2 (en) 1999-01-13 2011-03-01 Bayer Healthcare Llc ω-carboxyl aryl substituted diphenyl ureas as p38 kinase inhibitors
US8841330B2 (en) 1999-01-13 2014-09-23 Bayer Healthcare Llc Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US8071616B2 (en) 2002-02-11 2011-12-06 Bayer Healthcare Llc Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors
US8110587B2 (en) 2002-02-11 2012-02-07 Bayer Healthcare Llc Aryl ureas as kinase inhibitors
US7838541B2 (en) 2002-02-11 2010-11-23 Bayer Healthcare, Llc Aryl ureas with angiogenesis inhibiting activity
US9181188B2 (en) 2002-02-11 2015-11-10 Bayer Healthcare Llc Aryl ureas as kinase inhibitors
US8242147B2 (en) 2002-02-11 2012-08-14 Bayer Healthcare Llc Aryl ureas with angiogenisis inhibiting activity
US8618141B2 (en) 2002-02-11 2013-12-31 Bayer Healthcare Llc Aryl ureas with angiogenesis inhibiting activity
US7678811B2 (en) 2002-02-11 2010-03-16 Bayer Healthcare Llc Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors
US8076488B2 (en) 2003-02-28 2011-12-13 Bayer Healthcare Llc Bicyclic urea derivatives useful in the treatment of cancer and other disorders
US8796250B2 (en) 2003-05-20 2014-08-05 Bayer Healthcare Llc Diaryl ureas for diseases mediated by PDGFR
US8637553B2 (en) 2003-07-23 2014-01-28 Bayer Healthcare Llc Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
US8207166B2 (en) 2004-04-30 2012-06-26 Bayer Healthcare Llc Substituted pyrazolyl urea derivatives useful in the treatment of cancer

Similar Documents

Publication Publication Date Title
DE511468C (de) Verfahren zur Darstellung von 5-Chlor-2-amino-1-methoxybenzol
DE523437C (de) Verfahren zur Darstellung von 5-Chlor- und 5-Brom-2-amino-1-alkyloxy- und 1-aralkyloxybenzolen
DE503135C (de) Verfahren zur Darstellung von asymmetrischen Arylalkylhydrazinen
DE517195C (de) Verfahren zur Darstellung von Kuepenfarbstoffen
DE511951C (de) Verfahren zur Darstellung von ªÏ-Aminomethylbenzanthron
DE528988C (de) Verfahren zur Darstellung von Silicylverbindungen
DE522272C (de) Verfahren zur Darstellung von Pyracridon
DE581329C (de) Verfahren zur Darstellung von Crotonylaminoarylarsinsaeuren
DE545212C (de) Verfahren zur Darstellung von Derivaten des Dinaphthylendioxyds
DE513026C (de) Verfahren zur Darstellung von Benzimidazolonstibinsaeuren
DE515207C (de) Verfahren zur Darstellung von Oxyacylaminoarsenobenzolen
DE522058C (de) Verfahren zur Darstellung von Senfoelen
DE497243C (de) Verfahren zur Darstellung von Arylsulfamidooxynaphthalinsulfonsaeuren
DE510437C (de) Verfahren zur Darstellung von Benzimidazolonstibinsaeuren
DE583108C (de) Verfahren zur Darstellung von Dichlorcarvacrol
DE499322C (de) Verfahren zur Darstellung von 2-Mercaptoarylenthiazolen
DE597123C (de) Verfahren zur Darstellung von p-Oxyphenylmethylaminopropanol
DE498291C (de) Verfahren zur Darstellung von Phthaloylphenanthridonen
DE498051C (de) Verfahren zur Darstellung von N-monoacylierten Diaminoarsenobenzolen
DE504239C (de) Verfahren zur Darstellung von 2-Mercaptoarylenthiazolen
DE511738C (de) Verfahren zur Darstellung von Benzimidazolonstibinsaeuren
DE555408C (de) Verfahren zur Darstellung von substituierten Oxyphenoxyessigsaeuren
DE516286C (de) Verfahren zur Darstellung von 1-Oxy-4-chloranthrachinon-2-carbonsaeure
DE580696C (de) Verfahren zur Darstellung von 4-Bromdiaethylacetylamino-1-phenyl-2, 3-dimethyl-5-pyrazolon
DE517002C (de) Verfahren zur Darstellung von o-Phenolglycinamidarsinsaeuren